← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › PROPULSIVES › Propulsives
acotiamide
A03FA10
Adult Dosing
- 100 mg orally three times daily, taken before meals
Pediatric Dosing
- Safety and efficacy in pediatric patients have not been established
Indications
- Treatment of upper gastrointestinal symptoms associated with functional dyspepsia (postprandial distress syndrome)
Mechanism of Action
- Acetylcholinesterase inhibitor that enhances gastrointestinal motility
- Increases release of acetylcholine in the enteric nervous system by blocking presynaptic muscarinic autoreceptors
- Facilitates gastric emptying and improves gastric accommodation
Contraindications
- Hypersensitivity to acotiamide or any excipients
- Patients with gastrointestinal hemorrhage, mechanical obstruction, or perforation
Adverse Reactions
- Diarrhea
- Constipation
- Elevated serum prolactin
- Liver function test abnormalities (ALT, AST elevations)
- Leukopenia
Drug Interactions
- Anticholinergic agents may antagonize the gastrointestinal prokinetic effects of acotiamide
- No clinically significant cytochrome P450 drug-interactions identified based on in vitro metabolism profiles
Curated Content: Needs Vetting Before Put to Clinical Use